Lv5
1230 积分 2024-04-24 加入
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
16天前
已完结
Abstract 5980: AUBE00: A novel cyclic peptide pan-KRAS inhibitor targeting KRAS-activated cancers including KRAS-mutant cancers and wild-type colorectal cancer
16天前
已关闭
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
16天前
已完结
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
16天前
已完结
Targeting KRAS for Cancer Treatment: Is it Over Now?
16天前
已关闭
Targeting of fibroblast activation protein with [161Tb]Tb-FAP-2286 in treatment-refractory non-small cell lung cancer
2个月前
已完结
Advances With 225Ac-DOTATATE Targeted Alpha Therapy in Somatostatin Receptor Positive Neuroendocrine Tumors
2个月前
已完结
Clinical research analysis of [225Ac]Ac-PSMA-617 therapy for [177Lu]Lu-PSMA-refractory metastatic castration-resistant prostate cancer
3个月前
已完结
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study
3个月前
已完结
Novel bio-carriers for radionuclide delivery in cancer radiotherapy
6个月前
已完结
皖公网安备34019202002308
